Nerve growth factor as a potential treatment in Alzheimer's disease

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.

Original languageEnglish (US)
Pages (from-to)483-485
Number of pages3
JournalBiomedicine and Pharmacotherapy
Volume43
Issue number7
DOIs
StatePublished - Jan 1 1989

Fingerprint

Nerve Growth Factor
Alzheimer Disease
Clinical Trials
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{5a5420b4df0949e6b98be0ec5c9279db,
title = "Nerve growth factor as a potential treatment in Alzheimer's disease",
abstract = "An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.",
author = "Robert Harbaugh",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0753-3322(89)90108-X",
language = "English (US)",
volume = "43",
pages = "483--485",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "7",

}

Nerve growth factor as a potential treatment in Alzheimer's disease. / Harbaugh, Robert.

In: Biomedicine and Pharmacotherapy, Vol. 43, No. 7, 01.01.1989, p. 483-485.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nerve growth factor as a potential treatment in Alzheimer's disease

AU - Harbaugh, Robert

PY - 1989/1/1

Y1 - 1989/1/1

N2 - An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.

AB - An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.

UR - http://www.scopus.com/inward/record.url?scp=0024469207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024469207&partnerID=8YFLogxK

U2 - 10.1016/0753-3322(89)90108-X

DO - 10.1016/0753-3322(89)90108-X

M3 - Article

C2 - 2684291

AN - SCOPUS:0024469207

VL - 43

SP - 483

EP - 485

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 7

ER -